# Kavis Pharma LLC – FDA Inspection, Apr 9, 2025

Source: https://www.keypedia.com/records/fda_inspections/kavis-pharma-llc/2883cd81-2fd9-4592-8390-a87be4014aa4
Source feed: FDA_Inspections

> FDA inspection 1251850 of Kavis Pharma LLC, April 09, 2025. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1251850
- Company Name: Kavis Pharma LLC
- Inspection Date: 2025-04-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Dallas District Office
- Citation Count: 3

## Related Documents

- FDA Inspection 1059036 - 2018-06-01
- FDA Inspection 980284 - 2016-07-08
- [FDA Inspection 931462 - 2015-05-22](https://www.keypedia.com/records/fda_inspections/kavis-pharma-llc/c29bf512-98ea-4384-a00a-f85ecac7e7ac)
- FDA Inspection 783024 - 2012-05-23
- FDA Inspection 720951 - 2011-04-12

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/camerson-e-moore/50733244-0d55-4b0b-a758-f192b7c66457)

Company: https://www.keypedia.com/companies/kavis-pharma-llc/453e3985-3964-40f5-aeaf-89cd2cb6f954

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9
